Novus Therapeutics (NASDAQ:NVUS) Posts Quarterly Earnings Results, Beats Expectations By $0.18 EPS - Slater Sentinel

Novus Therapeutics (NASDAQ:NVUS) Posts Quarterly Earnings Results, Beats Expectations By $0.18 EPS  Slater Sentinel

Comments

Popular posts from this blog

Summary of Society for Maternal-Fetal Medicine (SMFM) Consult Series #52: Diagnosis and management of fetal growth restriction - Contemporary Obgyn

BTS Clinical Statement on air travel for passengers with respiratory disease - Thorax (BMJ)